Skip to main content
Journal cover image

Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.

Publication ,  Journal Article
Petersen, RP; Hanish, SI; Haney, JC; Miller, CC; Burfeind, WR; Tyler, DS; Seigler, HF; Wolfe, W; D'Amico, TA; Harpole, DH
Published in: J Thorac Cardiovasc Surg
January 2007

OBJECTIVES: The outcomes of patients with metastatic melanoma are poor. Although prognostic models have been developed to predict the occurrence of pulmonary metastasis from cutaneous melanoma, few data exist to define the outcomes of these patients once metastasis has occurred. The objective of this study was to discriminate predictors of survival for patients with pulmonary metastatic melanoma. METHODS: We found 1720 patients with pulmonary metastasis listed in a prospective comprehensive cancer center database of 14,057 consecutive patients with melanoma (Jan 1, 1970-June 1, 2004). Demographic and histopathologic data, time and location of recurrences, number of pulmonary nodules, and subsequent therapies were collected. Univariate and multivariate Cox proportional hazards models were used to identify predictors of survival for patients with pulmonary metastatic melanoma. RESULTS: The median survival was 7.3 months after development of pulmonary metastasis. Significant predictors of survival from the multivariate model included nodular histologic type (P = .033), disease-free interval (P < .001), number of pulmonary metastases (P = .012), presence of extrathoracic metastasis (P < .001), and performance of pulmonary metastasectomy (P < .001). Interactions were identified between metastasectomy and disease-free interval and presence of extrathoracic metastasis. Surgery was associated with a survival advantage of 12 months for patients with a disease-free interval longer than 5 years (19 vs 7 months, P < .01) and of 10 months for patients without extrathoracic metastasis (18 vs 8 months, P < .01). CONCLUSIONS: When all other identified risk factors were controlled for mathematically, metastasectomy maintained a significant survival advantage for patients with pulmonary metastatic melanoma. These data support the role of surgery for a select subset of patients with pulmonary metastasis.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

January 2007

Volume

133

Issue

1

Start / End Page

104 / 110

Location

United States

Related Subject Headings

  • Survival Rate
  • Skin Neoplasms
  • Respiratory System
  • Prognosis
  • Middle Aged
  • Melanoma
  • Male
  • Lung Neoplasms
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Petersen, R. P., Hanish, S. I., Haney, J. C., Miller, C. C., Burfeind, W. R., Tyler, D. S., … Harpole, D. H. (2007). Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg, 133(1), 104–110. https://doi.org/10.1016/j.jtcvs.2006.08.065
Petersen, Rebecca P., Steven I. Hanish, John C. Haney, Charles C. Miller, William R. Burfeind, Douglas S. Tyler, Hilliard F. Seigler, Walter Wolfe, Thomas A. D’Amico, and David H. Harpole. “Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.J Thorac Cardiovasc Surg 133, no. 1 (January 2007): 104–10. https://doi.org/10.1016/j.jtcvs.2006.08.065.
Petersen RP, Hanish SI, Haney JC, Miller CC, Burfeind WR, Tyler DS, et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 2007 Jan;133(1):104–10.
Petersen, Rebecca P., et al. “Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.J Thorac Cardiovasc Surg, vol. 133, no. 1, Jan. 2007, pp. 104–10. Pubmed, doi:10.1016/j.jtcvs.2006.08.065.
Petersen RP, Hanish SI, Haney JC, Miller CC, Burfeind WR, Tyler DS, Seigler HF, Wolfe W, D’Amico TA, Harpole DH. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 2007 Jan;133(1):104–110.
Journal cover image

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

January 2007

Volume

133

Issue

1

Start / End Page

104 / 110

Location

United States

Related Subject Headings

  • Survival Rate
  • Skin Neoplasms
  • Respiratory System
  • Prognosis
  • Middle Aged
  • Melanoma
  • Male
  • Lung Neoplasms
  • Humans
  • Female